CanBas Co.,Ltd. (4575)

Market cap
¥14.8B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
Period EndTotal assets (Million JPY)YoY (%)
Jun 30, 20253,051+25.40%
Jun 30, 20242,433+16.63%
Jun 30, 20232,086+163.81%
Jun 30, 2022791-38.97%
Jun 30, 20211,296+2.56%
Jun 30, 20201,263+44.31%
Jun 30, 2019875+51.37%
Jun 30, 2018578-41.78%
Jun 30, 2017993+2.69%
Jun 30, 2016967-3.07%
Jun 30, 2015998+151.05%
Jun 30, 2014397
AI Chat